EcoDrugPlus

Protein Arginine Methyltransferase 5

Ensembl ID : ENSCAFG00020007687
Gene Symbol: PRMT5
3 Cross references
199 Possible Orthologues:

Protein Kinase C Alpha

Ensembl ID : ENSCAFG00020025295
Gene Symbol: PRKCA
3 Cross references
213 Possible Orthologues:

Protein Kinase C Beta

Ensembl ID : ENSCAFG00020021309
Gene Symbol: PRKCB
3 Cross references
299 Possible Orthologues:

Protein Kinase C Delta

Ensembl ID : ENSCAFG00020004538
Gene Symbol: PRKCD
3 Cross references
283 Possible Orthologues:

Protein Kinase C Gamma

Ensembl ID : ENSCAFG00020018608
Gene Symbol: PRKCG
3 Cross references
200 Possible Orthologues:

Protein Kinase C Iota

Ensembl ID : ENSCAFG00020001182
Gene Symbol: PRKCI
3 Cross references
226 Possible Orthologues:

Protein Kinase C Theta

Ensembl ID : ENSCAFG00020005447
Gene Symbol: PRKCQ
3 Cross references
204 Possible Orthologues:

Protein Kinase C Zeta

Ensembl ID : ENSCAFG00020011330
Gene Symbol: PRKCZ
3 Cross references
201 Possible Orthologues:

Protein Kinase D1

Ensembl ID : ENSCAFG00020024128
Gene Symbol: PRKD1
3 Cross references
214 Possible Orthologues:

Protein Kinase D3

Ensembl ID : ENSCAFG00020022829
Gene Symbol: PRKD3
3 Cross references
274 Possible Orthologues:

Protein Kinase Camp-Activated Catalytic Subunit Alpha

Ensembl ID : ENSCAFG00020006939
Gene Symbol: PRKACA
3 Cross references
288 Possible Orthologues:

Protein Kinase Camp-Activated Catalytic Subunit Beta

Ensembl ID : ENSCAFG00020014330
Gene Symbol: PRKACB
3 Cross references
304 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).